利用行为经济学改善心力衰竭治疗和治疗结果
Leslie L Chang1, Adam D DeVore1, Bradi B Granger1
1From Duke Clinical Research Institute, Durham, NC (L.L.C., A.D.D., Z.J.E., A.F.H.); and School of Medicine (L.L.C., A.D.D., Z.J.E., A.F.H.), School of Nursing (B.B.G.), and Fuqua School of Business (D.A.), Duke University, Durham, NC.
Circulation
|August 23, 2017
概括
行为经济学为患者选择治疗慢性心力衰竭等疾病提供了洞察力. 应用这些原则可以改善患者对药物的坚持和促进更健康的决策.
科学领域:
- 健康行为
- 行为经济学
- 慢性疾病管理
背景情况:
- 在各种疾病中,行为挑战对患者的健康状况产生重大影响.
- 医疗政策的转变强调了医疗服务提供者对患者行为所带来的结果的责任.
- 关于将行为经济学应用于慢性疾病管理,特别是心力衰竭 (HF) 的研究有限.
研究的目的:
- 探索核心行为经济学概念对心力衰竭 (HF) 患者管理的应用.
- 检查行为经济学原则如何转化为改善HF护理的实际工具.
- 了解高血压患者的决策,以提高治疗的坚持和生活方式的选择.
主要方法:
- 对患者决策相关的核心行为经济学原则的审查.
- 探索从行为经济学中获得的潜在工具,如金融激励和社交网络.
- 分析这些工具如何解决心力衰竭管理中的行为变化障碍.
主要成果:
- 行为经济学为了解慢性病患者的选择提供了一个框架.
- 财政激励和社会网络是改善HF管理的有希望的干预措施.
- 了解患者的决策对于开发有效的行为干预至关重要.
结论:
- 行为经济学提供了新的方法来改善心力衰竭患者的治疗结果.
- 将行为经济学概念转化为实用工具可以提高药物服药量,促进健康行为.
- 对于慢性疾病管理, 需要进一步研究行为经济学的干预措施.
相关概念视频
Heart Failure V: Medical Management
400
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
400
Heart Failure VI: Adjunct Therapies
442
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
442
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
1.3K
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
1.3K
Heart Failure VII: Nursing Interventions
576
The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
576
Heart Failure II: Pathophysiology
1.1K
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.1K
Heart Failure I: Introduction
1.0K
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
1.0K


